Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized trial of follitropin delta vs GONAL-F for controlled ovarian stimulation in IVF/ICSI (China)
ChiCTR2500106936Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of follitropin delta in infertility, Tubal factor infertility (TFI), Unexplained infertility and 2 more (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Number of oocytes retrieved. Started Jul 2025; status: recruiting.
02
Drugs
follitropin delta
03
Conditions
infertilityTubal factor infertility (TFI)Unexplained infertilityendometriosismale infertility
Beyond the preview
Go deeper on ChiCTR2500106936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106936.